search icon
plur-img

Pluri Inc., Common Stock

PLUR

NAQ

$4.4656

+$0.24

(5.67%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$24.82M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
11.98K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.63
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$4.07 L
$8.48 H
$4.4656

About Pluri Inc., Common Stock

Pluri Inc., a biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and cell-based technologies for various industries. It develops placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions; and a novel immunotherapy platform. The company's product candidates include PLX-PAD, that is composed of maternal mesenchymal stromal cells originating from the placenta for the treatment of various indications, such as acute muscle injuries following hip fracture, acute respiratory distress syndrome due to COVID-19, peripheral artery disease, intermittent claudication, and critical limb ischemia; PLX-R18, is composed of fetal MSC like cells originating from the placenta for the treatment of hematopoietic complications of the H-ARS, and phase I trial to treat hematopoietic cell transplantation; and allogeneic MAIT cell therapy platform. It also offers cell manufacturing services; cell-based coffee; and develops and commercializes cultivated meat products. The company operates in the field of regenerative medicine, food-tech, CDMO, and agtech. It has collaboration agreement with Bar-Ilan University to advance cancer immunotherapy for solid tumors. The company was formerly known as Pluristem Therapeutics Inc. and changed its name to Pluri Inc. in July 2022. Pluri Inc. was incorporated in 2001 and is based in Haifa, Israel. more

Industry: BiotechnologySector: Health Care

Returns

Time FramePLURSectorS&P500
1-Week Return-3.76%0.31%-1.26%
1-Month Return-3.92%0.6%-4.16%
3-Month Return-10%-9.44%-0.46%
6-Month Return-21.1%-5.15%3.58%
1-Year Return1.82%0.33%22.47%
3-Year Return-71.08%4.53%25.13%
5-Year Return-86.39%35.98%77.7%
10-Year Return-98.01%100.72%190.12%

Financials

Jun '20Jun '21Jun '22Jun '23Jun '245YR TREND
Total Revenue23.00K-234.00K287.00K326.00K[{"date":"2020-06-30","value":7.06,"profit":true},{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":71.78,"profit":true},{"date":"2023-06-30","value":88.04,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Cost of Revenue1.57M50.62M41.59M9.00K4.00K[{"date":"2020-06-30","value":3.1,"profit":true},{"date":"2021-06-30","value":100,"profit":true},{"date":"2022-06-30","value":82.16,"profit":true},{"date":"2023-06-30","value":0.02,"profit":true},{"date":"2024-06-30","value":0.01,"profit":true}]
Gross Profit(1.55M)(50.62M)(41.36M)278.00K322.00K[{"date":"2020-06-30","value":-480.43,"profit":false},{"date":"2021-06-30","value":-15721.43,"profit":false},{"date":"2022-06-30","value":-12844.41,"profit":false},{"date":"2023-06-30","value":86.34,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Gross Margin(6726.09%)(Infinity%)(17674.79%)96.86%98.77%[{"date":"2020-06-30","value":-6809.64,"profit":false},{"date":"2021-06-30","value":null,"profit":false},{"date":"2022-06-30","value":-17894.35,"profit":false},{"date":"2023-06-30","value":98.07,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Operating Expenses29.50M50.62M41.83M27.52M22.48M[{"date":"2020-06-30","value":58.27,"profit":true},{"date":"2021-06-30","value":100,"profit":true},{"date":"2022-06-30","value":82.62,"profit":true},{"date":"2023-06-30","value":54.37,"profit":true},{"date":"2024-06-30","value":44.41,"profit":true}]
Operating Income(29.48M)(50.62M)(41.59M)(27.25M)(22.16M)[{"date":"2020-06-30","value":-2947600000,"profit":false},{"date":"2021-06-30","value":-5062300000,"profit":false},{"date":"2022-06-30","value":-4159300000,"profit":false},{"date":"2023-06-30","value":-2724600000,"profit":false},{"date":"2024-06-30","value":-2215800000,"profit":false}]
Total Non-Operating Income/Expense480.00K1.15M(112.00K)(1.42M)1.35M[{"date":"2020-06-30","value":35.45,"profit":true},{"date":"2021-06-30","value":84.86,"profit":true},{"date":"2022-06-30","value":-8.27,"profit":false},{"date":"2023-06-30","value":-104.58,"profit":false},{"date":"2024-06-30","value":100,"profit":true}]
Pre-Tax Income(29.15M)(49.87M)(41.37M)(28.89M)(21.34M)[{"date":"2020-06-30","value":-2915200000,"profit":false},{"date":"2021-06-30","value":-4986500000,"profit":false},{"date":"2022-06-30","value":-4137400000,"profit":false},{"date":"2023-06-30","value":-2888700000,"profit":false},{"date":"2024-06-30","value":-2134400000,"profit":false}]
Income Taxes196.00K78.00K(351.00K)277.00K410.00K[{"date":"2020-06-30","value":47.8,"profit":true},{"date":"2021-06-30","value":19.02,"profit":true},{"date":"2022-06-30","value":-85.61,"profit":false},{"date":"2023-06-30","value":67.56,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Income After Taxes(29.35M)(49.94M)(41.02M)(29.16M)(21.75M)[{"date":"2020-06-30","value":-2934800000,"profit":false},{"date":"2021-06-30","value":-4994300000,"profit":false},{"date":"2022-06-30","value":-4102300000,"profit":false},{"date":"2023-06-30","value":-2916400000,"profit":false},{"date":"2024-06-30","value":-2175400000,"profit":false}]
Income From Continuous Operations(29.15M)(49.87M)(41.37M)(28.89M)(21.34M)[{"date":"2020-06-30","value":-2915200000,"profit":false},{"date":"2021-06-30","value":-4986500000,"profit":false},{"date":"2022-06-30","value":-4137400000,"profit":false},{"date":"2023-06-30","value":-2888700000,"profit":false},{"date":"2024-06-30","value":-2134400000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-06-30","value":"-","profit":true},{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Net Income(29.35M)(49.94M)(41.02M)(28.32M)(20.89M)[{"date":"2020-06-30","value":-2934800000,"profit":false},{"date":"2021-06-30","value":-4994300000,"profit":false},{"date":"2022-06-30","value":-4102300000,"profit":false},{"date":"2023-06-30","value":-2832100000,"profit":false},{"date":"2024-06-30","value":-2088800000,"profit":false}]
EPS (Diluted)(1.60)(1.76)(1.29)(0.78)(2.38)[{"date":"2020-06-30","value":-160,"profit":false},{"date":"2021-06-30","value":-176,"profit":false},{"date":"2022-06-30","value":-129,"profit":false},{"date":"2023-06-30","value":-78,"profit":false},{"date":"2024-06-30","value":-238.12,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

PLUR
Cash Ratio 5.68
Current Ratio 5.90

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

PLUR
ROA (LTM) -30.67%
ROE (LTM) -206.07%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

PLUR
Debt Ratio Lower is generally better. Negative is bad. 1.00
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -0.15

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

PLUR
Trailing PE NM
Forward PE NM
P/S (TTM) 76.14
P/B 306.56
Price/FCF NM
EV/R 50.24
EV/Ebitda NM

FAQs

What is Pluri Inc. share price today?

Pluri Inc. (PLUR) share price today is $4.4656

Can Indians buy Pluri Inc. shares?

Yes, Indians can buy shares of Pluri Inc. (PLUR) on Vested. To buy Pluri Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in PLUR stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Pluri Inc. be purchased?

Yes, you can purchase fractional shares of Pluri Inc. (PLUR) via the Vested app. You can start investing in Pluri Inc. (PLUR) with a minimum investment of $1.

How to invest in Pluri Inc. shares from India?

You can invest in shares of Pluri Inc. (PLUR) via Vested in three simple steps:

  • Click on Sign Up or Invest in PLUR stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Pluri Inc. shares
What is Pluri Inc. 52-week high and low stock price?

The 52-week high price of Pluri Inc. (PLUR) is $8.48. The 52-week low price of Pluri Inc. (PLUR) is $4.07.

What is Pluri Inc. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Pluri Inc. (PLUR) is

What is Pluri Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Pluri Inc. (PLUR) is 306.56

What is Pluri Inc. dividend yield?

The dividend yield of Pluri Inc. (PLUR) is 0.00%

What is the Market Cap of Pluri Inc.?

The market capitalization of Pluri Inc. (PLUR) is $24.82M

What is Pluri Inc.’s stock symbol?

The stock symbol (or ticker) of Pluri Inc. is PLUR

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top